Abstract

SKIM LEAN aims at exploiting Electronic Health Records (EHRs) to integrate knowledge derived from routine laboratory tests with background analysis of clinical databases, for the identification and early referral to specialist care, where appropriate, of patients with hypercholesterolemia, who may be inadequately controlled according to their cardiovascular (CV) risk level. SKIM LEAN addresses gaps in care that may occur through the lack of coordination between primary and specialist care, incomplete adherence to clinical guidelines, or poor patient's compliance to the physician's prescriptions because of comorbidities or drug side effects. Key project objectives include: (1) improved health professionals' competence and patient empowerment through a two-tiered educational website for general practitioners (GPs) and patients, and (2) implementation of a hospital-community shared care pathway to increase the proportion of patients at high/very-high CV risk (Familial Hypercholesterolemia, previous CV events) who achieve target LDL cholesterol (LDL-C) levels. Thanks to a close collaboration between clinical and information technology partners, SKIM LEAN will fully exploit the value of big data deriving from EHRs, and filter such knowledge using clinically-derived algorithms to risk-stratify patients. Alerts for GPs will be generated with interpreted test results. GPs will be able to refer patients with uncontrolled LDL-C within the shared pathway to the lipid or secondary prevention outpatient clinics of NIG hospital. Metrics to verify the project achievements include web-site visits, the number of alerts generated, numbers of patients referred by GPs, the proportion of secondary prevention patients who achieve LDL-C <100 mg/dl or a >50% decrease from baseline.

Highlights

  • Ischemic heart disease and stroke are the world’s largest causes of death, accounting for a combined 15 million deaths in 20151 Ischemic heart disease has been estimated to be the leading cause of disability in Europe, accounting for approximately 10% of total disability-adjusted life years

  • - Increase in the overall proportion of patients with LDL cholesterol (LDL-C)

  • Based on the detailed criteria described in the method section, data from 25,116 patients with tests charged to the Regional Health service during 2016 and at least one valid LDL-C result available were identified

Read more

Summary

Introduction

Ischemic heart disease and stroke are the world’s largest causes of death, accounting for a combined 15 million deaths in 20151 Ischemic heart disease has been estimated to be the leading cause of disability in Europe, accounting for approximately 10% of total disability-adjusted life years. European studies have highlighted extensive underdiagnosis and undertreatment of hypercholesterolaemia, in some special populations, such as subjects with genetically-determined hypercholesterolemia (i.e., familial hypercholesterolemia), patients with known CVD (i.e., secondary prevention), diabetes or chronic kidney disease (CKD), as well as patients with high levels of individual risk factors (Nordestgaard et al, 2013; Reiner et al, 2013). In the literature reported FH prevalence rates range from 1:200 to 1:500 (Hopkins, 2003; Nordestgaard et al, 2013; Schmidt et al, 2017). Estimates from Australia, Olmstead County in Minnesota US and Italy reported a prevalence of probable/definite FH ranging from 1:146 to 1:556

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call